Uncategorized
Vizuro and DCB Join Forces to Revolutionize Drug Discovery and Precision Medicine with Causal Generative AI

Vizuro LLC, a leading innovator in multimodal causal AI technology, and the Development Center for Biotechnology (DCB) announced the signing of a Memorandum of Understanding (MOU) to collaboratively drive innovation and growth in the biotechnology and pharmaceutical industries.

This collaboration aims to establish a next-generation AI computational platform, advancing breakthroughs in drug discovery and accelerating the implementation of precision medicine. The partnership paves the way for groundbreaking advancements in the global biotech industry.
Vizuro LLC is a pioneering provider of multimodal causal AI technology with offices in Boston, USA, and Taipei, Taiwan. The company delivers actionable AI solutions across multiple industries, serving a global clientele over the past decade. Vizuro’s partnerships span organizations of all sizes, from Fortune 100 companies to emerging startups. In 2024, Vizuro was twice recognized as an exemplary vendor by Gartner in its Hype Cycle reports for AI technologies and advanced analytics in financial services.
DCB is a key player in Taiwan’s biotech value chain, and is recognized as “the best partner in the biotech industry”. Supported by the Department of Industrial Technology, Ministry of Economic Affairs R.O.C, DCB has been focusing on cancer drug development, precision medicine, and innovative therapies. To align with the global surge in AI advancements, DCB has established the IntelliBio division to pioneer AI-driven innovations in drug discovery.
The MOU outlines collaboration in nine major areas, including:
- Small-molecule drugs
- Antibody-drug conjugates (ADC)
- Bispecific antibodies
- Antisense oligonucleotides (ASO)
- Small interfering RNA (siRNA)
- Antibody-oligonucleotide conjugates (AOC)
- Induced pluripotent stem cells (iPSC)
- CAR-NK cell therapy
- Cancer vaccines
The partnership will also collaborate on securing resources from the Ministry of Economic Affairs, R.O.C., and NVIDIA’s “Taipei-1” A+ program to boost the platform’s AI computational capabilities. This enhanced capacity will support multimodal drug discovery and accelerate the clinical application of innovative therapies. By combining their unique expertise, Vizuro and DCB aim to create next-generation biotech products and platforms, driving progress in both research and commercial ventures.
“The causal generative AI platform developed by Vizuro enables significant advancements in drug discovery. It expands potential biological pathways, enhances target discovery, repositions drugs, and generates novel drug designs while identifying biomarkers suited for specific clinical populations. By combining DCB’s extensive expertise in drug development and startup incubation with Vizuro’s capabilities in causal and generative AI technology, this collaboration represents a powerful synergy. The integration of generative AI technology makes drug discovery processes more precise and efficient. This partnership with DCB opens new opportunities in drug discovery, injecting fresh momentum into the growth of Taiwan’s biotech and pharmaceutical industries.” Yu-Feng Wei, Co-Founder and CEO of Vizuro LLC, stated.
“Generative AI technology significantly enhances the efficiency of target exploration and drug design. By collaborating with Vizuro, a leader in generative AI, DCB aims to accelerate cancer drug development. This partnership is expected to yield niche, first-in-class, or best-in-class drugs while fostering an ecosystem for academic, industrial, and research collaborations in early-stage drug discovery. The ultimate goal is to deliver innovative medicines that benefit patients worldwide “ Dr. Hsing-Jer Tsou, DCB Chairman, emphasized.
“DCB’s robust preclinical drug development capabilities, with extensive experience in small-molecule drugs, biologics, and nucleic acid therapeutics. Vizuro, with offices in Boston and Taipei, specializes in generative AI and offers actionable AI solutions across various industries. Its expertise lies in combining deep learning and causal inference to identify biological targets and simulate drug designs from multimodal data. Together, DCB and Vizuro plan to build an AI computational platform to advance drug discovery and repositioning, efficiently finding new therapeutic uses for existing drugs. This will accelerate the development of cost-effective, precise, and rapid new medicines.” Dr. Chien-Yueh Huang, DCB Deputy Executive Director, highlighted.
This collaboration marks a major leap forward in generative AI in the biotechnology and pharmaceutical sectors. It establishes a new standard for integrating AI technologies and propelling Taiwan’s biotech industry into the global market.
Media Contact:
Vizuro LLC
Finnie Lu
Head of AI Marketing
Mobile: 886-903363701
Email: [email protected]
The post Vizuro and DCB Join Forces to Revolutionize Drug Discovery and Precision Medicine with Causal Generative AI appeared first on Pinion Newswire.
Uncategorized
Firex21 Capital: Shaping a New World Order Through the Goodwill of Capital The True Value of Investing Lies in Making the World a Better Place
Amid the tides of the global financial markets, one institution remains steadfast in its belief: capital is not merely a tool for returns, but a force for good. Firex21 Capital was born from a rethinking of the true essence of finance. We believe that truly great investments generate both returns and meaning.
From London, England, our founders Oliver Hawthorne and Theodore Ashcroft set out to disrupt tradition with technology and define direction through vision. They are not content serving only high-net-worth individuals—they are committed to democratizing and popularizing finance, enabling everyone, regardless of background, origin, or geography, to access a path toward wealth and dignity.
Mission-Driven, Not Profit-Obsessed
Firex21 Capital’s philanthropic strategy isn’t a branding move—it’s deeply embedded in the purpose of our existence. We firmly believe:
“We don’t just manage money—we are reshaping how resources are distributed.”
This marks a fundamental revolution in both investment logic and value systems.
We pledge:
- To allocate over 10% of annual profits to dedicated philanthropic funds.
- To evaluate every investment decision based on ESG impact and social contribution.
- To ensure all charitable funds are fully traceable and results-verified through blockchain systems.
Four Strategic Projects: Empowering the World Through Capital
Financial Empowerment for All
In many underdeveloped regions, financial education is still a distant luxury. We partner with local nonprofits to offer free courses in investing, financial planning, and entrepreneurship for youth and women, helping them break the cycle of poverty. We do not believe in “charity changes fate”—we believe knowledge is the true power to transform destinies.
Green Horizon Initiative
As the global climate crisis escalates, Firex21 Capital takes environmental responsibility seriously. We invest in carbon capture technology, renewable energy, and sustainable agriculture, and encourage our portfolio companies to commit to net-zero emissions. We believe economic growth and ecological preservation can go hand in hand.
Healthcare Without Borders
In a world where healthcare access is deeply unequal, Firex21 Capital focuses on technology-driven equity. We support AI-powered healthcare, mobile clinics, and telemedicine platforms—and reinvest returns into regions such as Africa and Southeast Asia to build basic healthcare networks. Health should be a fundamental human right, not a luxury.
Aspire Accelerator
We believe in the power of entrepreneurial spirit. In low-income communities across Latin America, Southeast Asia, and Africa, we provide zero-interest microloans, paired with mentorship and AstraQuant tech support, to help turn ideas into economic engines. We are not creating a group of “beneficiaries”—we are empowering a generation of changemakers.
Using Technology to Ensure Transparency, Using Systems to Guarantee Fairness
Firex21 Capital fully applies its core AstraQuant intelligent quant trading system to philanthropic governance:
Smart Insight Engine: Precisely identifies the regions and individuals most in need;
Whale Radar: Tracks the real-time flow of philanthropic funds, preventing waste.
QuickScore AI: Scientifically evaluates the input-output ratio of each charitable project, ensuring accountability.
AutoPilot Trade: Automatically allocates capital resources, enhancing operational efficiency and project delivery speed.
We know transparency is the foundation of trust, and technology is its safeguard.
We Are Not Merely “Giving Back”—We Are Redefining the Structure of Society
Firex21 Capital’s vision of philanthropy is not the traditional “giving by the wealthy.” We advocate for cooperative capitalism:
- Investing in education means empowering individuals to exercise free will.
- Investing in the environment means safeguarding our shared home.
- Investing in healthcare means restoring the dignity of life.
- Investing in entrepreneurship means unlocking the power to change one’s destiny.
We believe a truly healthy society isn’t made up of “givers” and “receivers,” but of an ecosystem where everyone participates and every dream has a chance to be realised.
Looking Ahead: Goodwill Is Not Just a Feeling—It Is Sustained Through Action
At Firex21 Capital, our goal is not to become the largest financial institution, but the most compassionate and responsible innovator in finance.
We will continue to:
- Expand our philanthropic reach across the U.S., Europe, Asia, and Africa.
- Bring in more like-minded investors to form the “Impact Capital Alliance”.
Advance global quant-driven philanthropy platforms and build a new model of financial empowerment. We are not fighting alone. We are inviting every changemaker to help redefine what “success” truly means.
Firex21 Capital — Turning Capital into a Gentle Weapon to Change the World. “Great investing isn’t just about growing wealth—it’s about growing humanity.”
Address: 1560 Broadway, Denver, CO 80202 (Civic Center)
The Press Release Firex21 Capital: Shaping a New World Order Through the Goodwill of Capital The True Value of Investing Lies in Making the World a Better Place appeared first on Pinion Newswire.
Uncategorized
Building the Enterprise-Grade Crypto Payment Hub: Cregis Unveils Next-Gen Infrastructure Solution at Money20/20

Cregis, a global leader in enterprise-grade crypto asset infrastructure, officially launched its next-generation Payment Engine at Money20/20 Asia 2025 in Bangkok. Combining cutting-edge technology with a global vision, Cregis is redefining the boundaries of “payment” for industries worldwide. In the post-pandemic era of accelerated digital transformation, payments have evolved beyond the “final step” in transactions—they are now the “first link” to industrial upgrading.
“More financial institutions and enterprise clients no longer view payments as a mere functional module but as a critical foundation for asset circulation, risk management, and compliance,” said Eric, Head of Business at Cregis ACPC. “At Cregis, we transform Web3’s foundational technologies into actionable enterprise capabilities.”
From “Payment Tool” to “Industrial Infrastructure”: Reinventing Business Efficiency
As an enterprise-focused crypto infrastructure provider, Cregis delivers secure, scalable asset management solutions through its self-custody MPC wallets and enterprise-grade Payment Engine. Serving over 3,500 institutions—including forex platforms, payment processors, and traditional banks—Cregis enables seamless digital asset operations and growth.
With modular API integration, businesses can effortlessly embed on-chain accounts, real-time settlements, and role-based risk controls into existing systems, advancing from “account-as-wallet” to “payment-as-clearing” workflows.
Tech-Driven Innovation: Bridging the Real Business World
Cregis’s Payment Engine powers diverse real-world applications:
- Forex & Payment Institutions: Multi-currency MPC custody ensures fund security and operational flexibility.
- Web3 & DeFi Platforms: Embedded wallets and automated revenue distribution streamline treasury management.
- Cross-Border E-Commerce & Supply Chains: Instant settlements and optimized fund routing reduce costs and enhance efficiency.
These innovations reflect Cregis’s deep industry insights and long-term commitment to unifying payments, accounts, and security.
Security & Compliance: The New Currency of Financial Collaboration
Amst tightening global regulations, compliance, security, and auditability are now non-negotiables for institutional payment infrastructure. Cregis integrates MPC multi-signature self-custody, AML/KYB protocols, and granular permission controls natively into its account framework, delivering transparent, institution-grade security.
Expanding the Ecosystem: Cregis Calls for Industry Collaboration
At Money20/20, Cregis aims to forge partnerships with traditional banks, forex platforms, VCs, and payment providers to explore deeper Web3-traditional finance convergence.
“The evolution of payment infrastructure isn’t just technological—it’s a reshaping of global collaboration,” Eric emphasized. “Cregis is committed to open dialogue and co-building the future of finance.”
As a key enabler of Asia-Pacific’s digital asset infrastructure, Cregis proves that payments connect more than funds—they bridge trust, efficiency, and the next era of global synergy.
About Cregis
Cregis provides enterprise-grade digital asset infrastructure, offering secure and scalable solutions for payments, custody and asset management. Trusted by institutions worldwide, Cregis is building the financial foundations for the Web3 economy.
LinkedIn: Cregis
Twitter: @0xCregis
The Press Release Building the Enterprise-Grade Crypto Payment Hub: Cregis Unveils Next-Gen Infrastructure Solution at Money20/20 appeared first on Pinion Newswire.
Uncategorized
New film “Zero Limits” Starring Secret Movie Star Dr. Joe Vitale to Premiere in Sacramento June 26
The film “Zero Limits” has already received high praise from critics, with many calling it a life-changing movie. It’s been nominated for 12 awards and won three, so far. “Zero Limits” has been described as a must-watch for anyone looking to improve their relationships, health, and overall well-being. Its unique blend of ancient wisdom and modern techniques makes it a valuable resource for anyone seeking personal growth and transformation.
“I’m on a quest to find out if anything is truly impossible or incurable,” says Vitale, who received the Los Angles Tribune Lifetime Achievement Award in 2021 and the US President Lifetime Achievement award in 2024.
“I created a film to give people hope, inspiration, and information,” he said. “I’m on a mission to get this message to the world suffering.”
The premiere of “Zero Limits” in Sacramento June 26 is highly anticipated, with limited VIP tickets selling out quickly. Attendees can expect an evening filled with inspiration, as Vitale shares his journey and insights from being homeless to becoming an international movie star and celebrated bestselling author, and is joined with many of the stars from the movie.
“The world is in pain,” Vitale, 71, explains. “Everyone is dazed and confused. Yet there is a way out, and we reveal it in the film.”
Media coverage includes the Los Angeles Tribune, as well as independent journalists and photographers. The event will also feature a meet-and-greet with the author and many members of the cast. “Zero Limits” is a film that has the power to change lives. The VIP red carpet premiere in Sacramento is not to be missed. Seating is limited. Tickets must be purchased in advance.
“I saw the what a good movie could do to help people by being in the movie The Secret,” says Vitale, author of The Miracle and The Attractor Factor. “I’ve wanted my own movie for ten years. I’m happy to say it’s ready for the world.”
For more information on “Zero Limits” the movie, and to purchase VIP tickets for the premiere, visit the official website at www.zerolimitsmovie.com.The movie will stream on Amazon and Apple TV later 2025.
Don’t miss the opportunity to learn from one of the world’s leading experts on ho’oponopono and discover the limitless potential within yourself.
The Press Release New film “Zero Limits” Starring Secret Movie Star Dr. Joe Vitale to Premiere in Sacramento June 26 appeared first on Pinion Newswire.
-
Entertainment & Sports9 months ago
Rachael Sage Releases Powerful Reimagined Acoustic Album, Another Side
-
Business9 months ago
Global Academic Excellence with XI TING’s Professional Tutor Team
-
Entertainment & Sports9 months ago
From Start to Success: 40 Stories of Successful C-Suite Executives Now Available for Pre-Order
-
Politics9 months ago
Musk Claims Trump Interview Targeted by Cyber Attack
-
Entertainment & Sports9 months ago
Thousands Celebrate Lisa Vanderpump’s 7th Annual World Dog Day in West Hollywood
-
Entertainment & Sports9 months ago
VetStem Cell Therapy Improves Quality of Life for Dog with Hip Arthritis
-
Crypto News9 months ago
Cubic Introduces DTECH Fusion Edge High-Performance Compute (eHPC) at Special Operations Forces Week
-
Politics9 months ago
Germany’s ports and China: How to reconcile openness, resilience and security?